{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:20:04Z","timestamp":1793064004457,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.14283\/jpad.2024.139","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T08:58:58Z","timestamp":1719478738000},"page":"869-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Zahra","family":"Shirzadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Properzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-Y. W.","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Brickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Rafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ernstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"C.R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.139_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40478-015-0240-0","article-title":"Cortical tau load is associated with white matter hyperintensities","volume":"3","author":"McAleese","year":"2015","journal-title":"Acta Neuropathol. Commun"},{"key":"10.14283\/jpad.2024.139_bib2","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1212\/01.wnl.0000249119.95747.1f","article-title":"Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD","volume":"67","author":"Yoshita","year":"2006","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.139_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann. Neurol"},{"key":"10.14283\/jpad.2024.139_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/62.12.1287","article-title":"Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis\/Lipohyalinosis with Cognitive Decline","volume":"62","author":"Thal","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.14283\/jpad.2024.139_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/0271678X20957604","article-title":"Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns","volume":"41","author":"P\u00e5lhaugen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.14283\/jpad.2024.139_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2024.139_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","article-title":"Progression of cerebral amyloid angiopathy: a pathophysiological framework","volume":"22","author":"Koemans","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2024.139_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.3618","article-title":"Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease","author":"Shirzadi","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.139_bib9","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.139_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.14283\/jpad.2022.56","article-title":"Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid","volume":"9","author":"Yaari","year":"2022","journal-title":"J. Prev. Alzheimers Dis"},{"key":"10.14283\/jpad.2024.139_bib11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in Preclinical Alzheimer's Disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.14283\/jpad.2024.139_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2024.139_bib13","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hbm.25784","article-title":"Deep Bayesian networks for uncertainty estimation and adversarial resistance of white matter hyperintensity segmentation","volume":"43","author":"Mojiri Forooshani","year":"2022","journal-title":"Hum. Brain Mapp"},{"key":"10.14283\/jpad.2024.139_bib14","article-title":"Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort","volume":"9","author":"Kantarci","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.139_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2012.02.084","article-title":"Within-subject template estimation for unbiased longitudinal image analysis","volume":"61","author":"Reuter","year":"2012","journal-title":"NeuroImage"},{"key":"10.14283\/jpad.2024.139_bib16","first-page":"16","article-title":"Tau positron emission tomography in preclinical Alzheimer's disease","volume":"139","author":"Insel","year":"2022","journal-title":"Brain"},{"key":"10.14283\/jpad.2024.139_bib17","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch. Neurol"},{"key":"10.14283\/jpad.2024.139_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","article-title":"Progression of cerebral amyloid angiopathy: a pathophysiological framework","volume":"22","author":"Koemans","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2024.139_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.26429","article-title":"Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy","volume":"92","author":"Shirzadi","year":"2022","journal-title":"Ann. Neurol"},{"key":"10.14283\/jpad.2024.139_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.0983","article-title":"APOE Genotype and White Matter Hyperintensities in Sporadic Alzheimer Disease-Reply","author":"Shirzadi","year":"2024","journal-title":"JAMA Neurol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:07:21Z","timestamp":1737338841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2274580724000098"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.139","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}